Whole Genome Sequencing (Mean 30x) NGS Panel, EDTA

Clinical‑grade whole genome sequencing (mean 30×) from EDTA blood collected at home delivers a near‑complete, base‑level view of your genome to identify single nucleotide variants, small indels, copy‑number changes and many structural variants using high‑coverage NGS. This service supports diagnosis of rare or undiagnosed conditions, carrier screening, pharmacogenomic guidance and familial risk assessment and is available across Dubai and the UAE with trained phlebotomists performing home collection. Results include a clinician‑oriented report with prioritized findings and recommended follow‑up; interpretation and management should be undertaken with your treating physician or a genetic counselor in the UAE and any limitations (for example low‑coverage regions or repeat expansions) will be clearly stated.

• Mean coverage 30× (genome-wide)
• Single nucleotide variants (SNVs) and small insertions/deletions (indels)
• Copy number variants (CNVs)
• Structural variants (SVs) including translocations and inversions
• Mitochondrial genome variants and pharmacogenomic (PGx) markers with clinical annotation

• Clinical-grade whole genome sequencing with mean 30x coverage for high-confidence SNV and indel detection
• Convenient home blood collection by certified phlebotomists using EDTA tubes across Dubai and the UAE
• Comprehensive variant analysis including SNVs, indels, copy-number and structural variant detection with clinical annotation
• Actionable clinical report including pharmacogenomics insights and hereditary risk interpretation for personalized care
• Secure digital delivery, UAE-relevant data privacy safeguards, and optional post-test genetic counselling referrals

• Clinical-grade whole genome sequencing at mean 30× coverage for comprehensive detection of SNVs, indels, CNVs and structural variants
• Home blood collection in EDTA tube by trained phlebotomist across Dubai and the UAE for convenient sample pickup
• Clinically interpreted report with ACMG-guided variant classification, carrier screening and pharmacogenomic insights for personalized care
• Secure, physician-ready summary with typical turnaround of 4–8 weeks and optional delivery of VCF/FASTQ raw data on request
• Confidential data handling and post-report genetic consultation from certified specialists to support clinical follow-up in UAE healthcare settings

• Clinical-grade whole genome sequencing (mean 30×) for high-confidence detection of SNVs, indels, CNVs and structural variants
• Home blood collection in EDTA tubes by certified phlebotomists across Dubai and the UAE
• Comprehensive, clinician-ready report including pathogenic variants, carrier status and pharmacogenomic insights
• Secure, UAE-compliant data handling with optional post-test genetic counseling and specialist referral